Literature DB >> 19906330

Time-dependent migration of systemically delivered bone marrow mesenchymal stem cells to the infarcted heart.

Ana Carolina M Assis1, Juliana L Carvalho, Bruno A Jacoby, Raphael L B Ferreira, Paula Castanheira, Simone O F Diniz, Valbert N Cardoso, Alfredo M Goes, Anderson J Ferreira.   

Abstract

In this study the time course of homing and the body distribution of systemically delivered bone marrow mesenchymal stem cells (BM-MSCs) after myocardial infarction (MI) were evaluated. BM-MSCs were isolated from Wistar rats, expanded in vitro, and their phenotypical characterization was performed by flow cytometer. Rats were randomly divided into three groups: control, sham MI, and MI. BM-MSCs (5 x 10(6)) were labeled with (99m)Tc-HMPAO and injected through the tail vein 7 days after MI. Gamma camera imaging was performed at 5, 15, 30, and 60 min after cell inoculation. Due to the (99m)Tc short half-life, cell migration and location were also evaluated in heart sections using DAPI-labeled cells 7 days after transplantation. Phenotypical characterization showed that BM-MSCs were CD90(+), CD73(+), CD54(+), and CD45(-). Five minutes after (99m)Tc-HMPAO-labeled cell injection, they were detected in various tissues. The cells migrated mainly to the lungs (approximately 70%) and, in small amounts, to the heart, kidneys, spleen, and bladder. The number of cells in the heart and lungs decreased after 60 min. MI markedly increased the amount of cells in the heart, but not in the lungs, during the period of observation (4.55 +/- 0.32 vs. 6.34 +/- 0.67% of uptake in infarcted hearts). No significant differences were observed between control and sham groups. Additionally, 7 days after DAPI-labeled cells injection, they were still detected in the heart but only in infarcted areas. These results suggest that the migration of systemically delivered BM-MSCs to the heart is time dependent and MI specifically increases BM-MSCs homing to injured hearts. However, the systemic delivery is limited by cell entrapment in the lungs.

Entities:  

Mesh:

Year:  2009        PMID: 19906330     DOI: 10.3727/096368909X479677

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  54 in total

Review 1.  Concise review: mesoangioblast and mesenchymal stem cell therapy for muscular dystrophy: progress, challenges, and future directions.

Authors:  Suzanne E Berry
Journal:  Stem Cells Transl Med       Date:  2014-11-12       Impact factor: 6.940

2.  Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion.

Authors:  Ke Cheng; Konstantinos Malliaras; Tao-Sheng Li; Baiming Sun; Christiane Houde; Giselle Galang; Jeremy Smith; Noriko Matsushita; Eduardo Marbán
Journal:  Cell Transplant       Date:  2012-03-08       Impact factor: 4.064

Review 3.  SPECT and PET to optimize cardiac stem cell therapy.

Authors:  Angel T Chan; M Roselle Abraham
Journal:  J Nucl Cardiol       Date:  2012-02       Impact factor: 5.952

4.  Impact of indium-111 oxine labelling on viability of human mesenchymal stem cells in vitro, and 3D cell-tracking using SPECT/CT in vivo.

Authors:  Franz Josef Gildehaus; Florian Haasters; Inga Drosse; Erika Wagner; Christian Zach; Wolf Mutschler; Paul Cumming; Peter Bartenstein; Matthias Schieker
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

Review 5.  The role of chemokines in mesenchymal stem cell homing to myocardium.

Authors:  Yaojiong Wu; Robert C H Zhao
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 6.  Stem Cell Monitoring with a Direct or Indirect Labeling Method.

Authors:  Min Hwan Kim; Yong Jin Lee; Joo Hyun Kang
Journal:  Nucl Med Mol Imaging       Date:  2015-10-22

Review 7.  Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease.

Authors:  Sudhir H Ranganath; Oren Levy; Maneesha S Inamdar; Jeffrey M Karp
Journal:  Cell Stem Cell       Date:  2012-03-02       Impact factor: 24.633

Review 8.  Stem cell mechanisms during left ventricular remodeling post-myocardial infarction: Repair and regeneration.

Authors:  Rogelio Zamilpa; Mary M Navarro; Iris Flores; Sy Griffey
Journal:  World J Cardiol       Date:  2014-07-26

9.  Doxorubicin Cardiotoxicity and Cardiac Function Improvement After Stem Cell Therapy Diagnosed by Strain Echocardiography.

Authors:  Maira S Oliveira; Marcos B Melo; Juliana L Carvalho; Isabela M Melo; Mario Sl Lavor; Dawidson A Gomes; Alfredo M de Goes; Marilia M Melo
Journal:  J Cancer Sci Ther       Date:  2013

10.  Reduced migration of Ishikawa cells associated with downregulation of aquaporin-5.

Authors:  Xiu Xiu Jiang; Kai Hong Xu; Jun Yan Ma; Yong Hong Tian; Xiao Yan Guo; Jun Lin; Rui Jin Wu
Journal:  Oncol Lett       Date:  2012-05-30       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.